Dirk Thye

Dr. Dirk Thye, MD, is a CEO, Director & Chief Medical Officer at Quince Therapeutics, Inc. He is on the Board of Directors at Quince Therapeutics, Inc. Dr. Thye was previously employed as a Chief Executive Officer & Director by Novosteo, Inc., a President, CEO, CFO, Secretary & Director by Agenovir Corp., an Executive Chairman by Geom Therapeutics, Inc., a Chief Medical Officer by Cidara Therapeutics, Inc., a Founder by Pfluent, Inc., a Manager-Business Process by Quality Planning Corp, a Principal by Inclin, Inc., a President by Cerexa, Inc., and a Senior Vice President-Clinical Development by Peninsula Pharmaceuticals, Inc. He also served on the board at Kalyra Pharmaceuticals, Inc. He received his undergraduate degree from the University of California, Berkeley and a graduate degree from the University of California, Los Angeles.